Presentation is loading. Please wait.

Presentation is loading. Please wait.

Figure 1. Randomization and dropouts.

Published byBrigitta Budainé Modified over 5 years ago

Similar presentations

Presentation on theme: "Figure 1. Randomization and dropouts."— Presentation transcript:

1 Figure 1. Randomization and dropouts.
Unless provided in the caption above, the following copyright applies to the content of this slide: Copyright © 2018 Endocrine Society J Clin Endocrinol Metab, Volume 103, Issue 11, 07 September 2018, Pages 4014–4022, The content of this slide may be subject to copyright: please see the slide notes for details.

2 Figure 2. PL + PL (open circles), DZX-PL and DZX-MTF combined (open and closed circles), and the 16 men completing 1 y ... Figure 2. PL + PL (open circles), DZX-PL and DZX-MTF combined (open and closed circles), and the 16 men completing 1 y of DZX treatment according to protocol (closed circles) and reported PL-associated weight loss in large trials (solid line with 95% CI, dotted lines) (2, 3). Unless provided in the caption above, the following copyright applies to the content of this slide: Copyright © 2018 Endocrine Society J Clin Endocrinol Metab, Volume 103, Issue 11, 07 September 2018, Pages 4014–4022, The content of this slide may be subject to copyright: please see the slide notes for details.

3 Figure 3. Curve fit of the change (∆) in body FM as a function of fasting-Ins6. Each solid circle represents ... Figure 3. Curve fit of the change (∆) in body FM as a function of fasting-Ins<sub>6</sub>. Each solid circle represents men in either the PL-PL, or DZX group. The crossed lines show the fasting insulin level below which fat loss of at least 10 kg occurred. The dashed horizontal line is “zero weight loss line.” Unless provided in the caption above, the following copyright applies to the content of this slide: Copyright © 2018 Endocrine Society J Clin Endocrinol Metab, Volume 103, Issue 11, 07 September 2018, Pages 4014–4022, The content of this slide may be subject to copyright: please see the slide notes for details.

Download ppt "Figure 1. Randomization and dropouts."

Similar presentations

Fig. 1. Time line for investigations

Fig. 1. Time line for investigations
Figure 1. Total (A) and free (B) T, estradiol (C), and SHBG (D) levels at baseline and during treatment. From: Testosterone Treatment and Sexual Function.

Figure 1. Total (A) and free (B) T, estradiol (C), and SHBG (D) levels at baseline and during treatment. From: Testosterone Treatment and Sexual Function.
Fig. 4. Relationships of changes in CRP or SAA to changes in body weight and insulin resistance. For each comparison the regression line is shown (solid.

Fig. 4. Relationships of changes in CRP or SAA to changes in body weight and insulin resistance. For each comparison the regression line is shown (solid.
Figure 1. MRI study demonstrating the change in visceral and sc abdominal fat area in a typical pioglitazone-treated patient. Each picture shows a transverse.

Figure 1. MRI study demonstrating the change in visceral and sc abdominal fat area in a typical pioglitazone-treated patient. Each picture shows a transverse.
Unless provided in the caption above, the following copyright applies to the content of this slide: © 2019 European Society of Cardiology and British Pharmacological.

Unless provided in the caption above, the following copyright applies to the content of this slide: © 2019 European Society of Cardiology and British Pharmacological.
Unless provided in the caption above, the following copyright applies to the content of this slide: Published by Oxford University Press on behalf of the.

Unless provided in the caption above, the following copyright applies to the content of this slide: Published by Oxford University Press on behalf of the.
Figure 1 Approximate timeline contrasting major historical events in the understanding of ulcerative colitis (red) and ... Figure 1 Approximate timeline.

Figure 1 Approximate timeline contrasting major historical events in the understanding of ulcerative colitis (red) and ... Figure 1 Approximate timeline.
Figure 1 Data-selection process

Figure 1 Data-selection process
Figure 1 Flow diagram detailing the systematic review process.

Figure 1 Flow diagram detailing the systematic review process.
Figure 1 Schematic representation of the experimental design.

Figure 1 Schematic representation of the experimental design.
Figure 1 Mechanism of mortality benefit associated with radial access

Figure 1 Mechanism of mortality benefit associated with radial access
Figure 1 Number of percutaneous coronary interventions (PCI) in mainland China, 2017 (total 753 142). Data from China ... Figure 1 Number of percutaneous.

Figure 1 Number of percutaneous coronary interventions (PCI) in mainland China, 2017 (total 753 142). Data from China ... Figure 1 Number of percutaneous.
FIGURE 1 PRISMA flow diagram of studies in systematic review

FIGURE 1 PRISMA flow diagram of studies in systematic review
FIGURE 1 Patient enrolment flowchart. SBS, short bowel syndrome.

FIGURE 1 Patient enrolment flowchart. SBS, short bowel syndrome.
FIGURE 1 Flowchart of the study population.

FIGURE 1 Flowchart of the study population.
Unless provided in the caption above, the following copyright applies to the content of this slide: Published by Oxford University Press on behalf of the.

Unless provided in the caption above, the following copyright applies to the content of this slide: Published by Oxford University Press on behalf of the.
Figure 1 Mean (±SE) egg investment in female zebra finches shortly after a second injection with either tetanus toxoid ... Figure 1 Mean (±SE) egg investment.

Figure 1 Mean (±SE) egg investment in female zebra finches shortly after a second injection with either tetanus toxoid ... Figure 1 Mean (±SE) egg investment.
Figure 1 The Kaplan–Meier curves of time to death post first hospitalization. hosp, hospitalization. Unless provided in the caption above, the following.

Figure 1 The Kaplan–Meier curves of time to death post first hospitalization. hosp, hospitalization. Unless provided in the caption above, the following.
Figure 1 A dot plot illustrating the correlation between the yearly absolute risk difference for both MACE and major ... Figure 1 A dot plot illustrating.

Figure 1 A dot plot illustrating the correlation between the yearly absolute risk difference for both MACE and major ... Figure 1 A dot plot illustrating.
Figure 1 (A) Distributions of model (prey; dashed line) and Mimic (predator; solid line) cue values, showing ... Figure 1 (A) Distributions of model (prey;

Figure 1 (A) Distributions of model (prey; dashed line) and Mimic (predator; solid line) cue values, showing ... Figure 1 (A) Distributions of model (prey;

Similar presentations

Ads by Google